Flexion Therapeutics, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Flexion Therapeutics, Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$81.08 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2021-11-12
- Flexion Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2021-09-30 was -$30.31M.
- Flexion Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2021-06-30 was -$22.21M.
- Flexion Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2021-03-31 was -$28.56M.
- Flexion Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-12-31 was -$19.65M.
- Flexion Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$113.71M.
- Flexion Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$149.77M.
- Flexion Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2018 was -$169.66M.
- Flexion Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2016 was -$71.89M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$30.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$52.52M derived: sum of 2 quarters · filed 2021-11-12 | -$81.08M 10-Q · filed 2021-11-12 | -$100.72M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | -$22.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$50.76M 10-Q · filed 2021-08-04 | -$70.41M derived: sum of 3 quarters · filed 2021-08-04 | -$95.05M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | -$28.56M 10-Q · filed 2021-05-12 | -$48.20M derived: sum of 2 quarters · filed 2021-05-12 | -$72.84M derived: sum of 3 quarters · filed 2021-11-12 | -$105.46M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | -$19.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$44.28M derived: sum of 2 quarters · filed 2021-11-12 | -$76.90M derived: sum of 3 quarters · filed 2021-11-12 | -$113.71M 10-K · filed 2021-03-10 |
| 2020-09-30 | -$24.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$57.26M derived: sum of 2 quarters · filed 2021-11-12 | -$94.06M 10-Q · filed 2021-11-12 | -$127.58M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$32.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$69.42M 10-Q · filed 2021-08-04 | -$102.94M derived: sum of 3 quarters · filed 2021-08-04 | -$141.17M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | -$36.80M 10-Q · filed 2021-05-12 | -$70.32M derived: sum of 2 quarters · filed 2021-05-12 | -$108.55M derived: sum of 3 quarters · filed 2021-05-12 | -$145.04M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$33.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$71.75M derived: sum of 2 quarters · filed 2021-03-10 | -$108.23M derived: sum of 3 quarters · filed 2021-03-10 | -$149.77M 10-K · filed 2021-03-10 |
| 2019-09-30 | -$38.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$74.72M derived: sum of 2 quarters · filed 2020-11-04 | -$116.26M 10-Q · filed 2020-11-04 | -$156.83M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | -$36.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$78.03M 10-Q · filed 2020-08-05 | -$118.60M derived: sum of 3 quarters · filed 2021-03-10 | -$162.24M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | -$41.54M 10-Q · filed 2020-05-07 | -$82.11M derived: sum of 2 quarters · filed 2021-03-10 | -$125.75M derived: sum of 3 quarters · filed 2021-03-10 | -$169.63M derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | -$40.58M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$84.22M derived: sum of 2 quarters · filed 2021-03-10 | -$128.09M derived: sum of 3 quarters · filed 2021-03-10 | -$169.66M 10-K · filed 2021-03-10 |
| 2018-09-30 | -$43.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$87.52M derived: sum of 2 quarters · filed 2019-11-07 | -$129.08M 10-Q · filed 2019-11-07 | -$179.61M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-06-30 | -$43.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$85.44M 10-Q · filed 2019-08-06 | -$135.97M derived: sum of 3 quarters · filed 2020-05-20 | -$170.16M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-03-31 | -$41.57M 10-Q · filed 2019-05-08 | -$92.10M derived: sum of 2 quarters · filed 2020-05-20 | -$126.29M derived: sum of 3 quarters · filed 2020-05-20 | |
| 2017-12-31 | -$50.53M derived: 8-K 12 month − 10-Q 9 month · filed 2020-05-20 | -$84.72M derived: sum of 2 quarters · filed 2020-05-20 | -$137.48M 8-K · filed 2020-05-20 | |
| 2017-09-30 | -$34.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$86.95M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$52.76M 10-Q · filed 2018-08-07 | |||
| 2016-12-31 | -$71.89M 10-K · filed 2019-02-28 |